Question 1

Does MetLife Investment Management own ALPN stock?

Accepted Answer

As of its Q1 2024 13F, MetLife Investment Management held 19,701 shares of ALPN (Alpine Immune Sciences), worth $780,948.

Question 2

How many shares of ALPN does MetLife Investment Management own?

Accepted Answer

As of its Q1 2024 13F, MetLife Investment Management held 19,701 shares of ALPN (Alpine Immune Sciences).

Question 3

What is MetLife Investment Management's ALPN position worth?

Accepted Answer

As of its Q1 2024 13F, MetLife Investment Management's ALPN position was worth $780,948.

Question 4

When did MetLife Investment Management first buy ALPN?

Accepted Answer

MetLife Investment Management first reported ALPN in its Q4 2022 13F and listed it in 6 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2024-Q2 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2024-Q1	Increased	19,701	+17.1%	$780,948	0.0%	—	29
2023-Q4	Unchanged	16,818	0.0%	$320,551	0.0%	—	0
2023-Q3	Unchanged	16,818	0.0%	$192,566	0.0%	—	0
2023-Q2	Increased	16,818	+39.8%	$172,889	0.0%	—	30
2023-Q1	Unchanged	12,028	0.0%	$92,857	0.0%	—	0
2022-Q4	New	12,028	-	$88,406	0.0%	—	30

ALPN7 quarters

ALPN
7 quarters